Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Alzheimer Disease Clinical Trials

72 recruiting trials for Alzheimer Disease. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
72
Total Trials
72
Recruiting Now
4
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and...

Sponsor: Sanguine BiosciencesEnrolling: 200001 location
RECRUITINGNCT06377033

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

Given the expansion of indications for genetic testing and our understanding of conditions for which the results change medical management, it is imperative to consider novel ways...

Sponsor: University of PennsylvaniaEnrolling: 10001 location
RECRUITINGPhase 3NCT07011745

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With...

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.

Sponsor: Bristol-Myers SquibbEnrolling: 35220 locations
RECRUITINGNCT05372172

Tennessee Alzheimer's Project

The primary objective of the Vanderbilt Alzheimer's Disease Research Center (VADRC) is to provide local and national researchers with access to a well-characterized and diverse...

Sponsor: Vanderbilt University Medical CenterEnrolling: 10001 location
RECRUITINGPhase 2NCT04902703

Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease

A medicine that is FDA-approved for bone marrow stimulation (called sargramostim) will be tested for its safety and efficacy in individuals with mild-to-moderate Alzheimer's...

Sponsor: University of Colorado, DenverEnrolling: 421 location
RECRUITINGNCT05748613

Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's

The goal of this clinical trial is to test the effectiveness of a computerized anxiety sensitivity treatment (CAST) compared to a health education control (HEC) in older adults...

Sponsor: Florida State UniversityEnrolling: 3883 locations
RECRUITINGNCT05508841

Understanding How Alzheimer's Disease Impacts the Therapeutic Response to Transcranial Direct Current Stimulation

There is currently little symptomatic therapy for Alzheimer's Disease (AD) and nothing effective for individuals with Frontotemporal dementia (FTD). However, neuromodulation with...

Sponsor: BaycrestEnrolling: 421 location
RECRUITINGNCT06068361

Diagnostic Evaluation of Dementia with Lewy Bodies Using a Multimodal Approach

Dementia with Lewy body disease (DLB) is the second leading cause of degenerative cognitive disorder after Alzheimer's disease (AD). Its variable clinical expression makes...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 1301 location
RECRUITINGNCT06608589

CONSTELLATIONS Living Lab: Improving the Care Transitions of Older Adults Living with Neurocognitive Disorders

The prevalence of major neurocognitive disorders (MNCDs), particularly Alzheimer's disease, among older adults is increasing. These individuals and their caregivers often face...

Sponsor: Laval UniversityEnrolling: 7001 location
RECRUITINGNCT05846984

Learning Skills Together Family Caregiver Complex Intervention

Learning Skills Together (LST) is a 6-week psychoeducational intervention focused on complex care (nursing) tasks completed by family caregivers to persons living with Alzheimer's...

Sponsor: Case Western Reserve UniversityEnrolling: 2001 location
RECRUITINGNCT05597410

Shanghai At Risk for Alzheimer's Disease: a Cohort Study

The goal of this cohort study is to estimate the incidence of AD in the first-degree relatives of patients with AD. The main questions it aims to answer are: * cognitive changes...

Sponsor: Ruijin HospitalEnrolling: 34181 location
RECRUITINGNCT03217396

Biomarkers of Synaptic Damage in Multiple Sclerosis

A prospective and retrospective cohort study of about five years will be performed on blood and cerebrospinal fluid samples taken for diagnostic reasons from recruited patients...

Sponsor: Neuromed IRCCSEnrolling: 3001 location
RECRUITINGPhase 2NCT03503331

UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy

The primary objective of this study is to measure the concentration and the regional brain distribution of pathologic amyloid deposition using the PET tracer \[C-11\]PiB in...

Sponsor: University of Alabama at BirminghamEnrolling: 1601 location
RECRUITINGNCT06678100

Swallowing Impairments in Adults With and Without Alzheimer's Disease

This research study is investigating whether people with Alzheimer's disease (AD) experience more changes to swallowing than their healthy age-matched peers. The prevalence of...

Sponsor: Vanderbilt University Medical CenterEnrolling: 2401 location
RECRUITINGNCT04865172

ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions

ECOCAPTURE@HOME is a study which is currently being developed with the objective to capture the behavioral signature of apathy in everyday life context through remote monitoring...

Sponsor: Institut National de la Santé Et de la Recherche Médicale, FranceEnrolling: 1201 location
RECRUITINGNCT07036328

Transcranial Magnetic Stimulation to Slow Down Cognitive Decline in Alzheimer's Disease

New amyloid-targeting drugs for Alzheimer's disease (AD) offer minimal or unclear efficacy and often cause adverse events, highlighting the need for new therapies. In recent...

Sponsor: Willem de HaanEnrolling: 621 location
RECRUITINGNCT03799991

Vestibular Therapy in Alzheimer's Disease

Nearly 2 out of 3 patients with Alzheimer's disease (AD) experience problems with balance and mobility, which places such patients at increased risk of falling. The vestibular...

Sponsor: Johns Hopkins UniversityEnrolling: 1001 location
RECRUITINGPhase 3NCT05456503

PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620

The investigators will compare \[18F\]-PI-2620 tau PET scans from patients with frontotemporal lobar degeneration (FTLD), patients with non-amnestic presentations of Alzheimer's...

Sponsor: University of PennsylvaniaEnrolling: 721 location
RECRUITINGNCT06793735

Effectiveness of TeleVR App in Cognitive Decline and MCI Patients

The goal of this clinical trial is to evaluate the effectiveness of a telerehabilitation program combined with a virtual reality (VR) app in improving cognitive performance and...

Sponsor: IRCCS Centro Neurolesi Bonino PulejoEnrolling: 4801 location
RECRUITINGNCT07075770

Novel Personalized Non Invasive Combined Magnetic and Electrical Stimulation of the DMN in Mild AD Patients

Alzheimer's disease (AD) is increasingly recognized as a disorder marked by early synaptic dysfunction and disrupted brain network connectivity, beyond the traditional focus on...

Sponsor: I.R.C.C.S. Fondazione Santa LuciaEnrolling: 602 locations
RECRUITINGNCT06965062

Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)

Alzheimer's disease (AD), one of the most common causes of dementia in Singapore and the developed world, is a neurodegenerative disorder with high socioeconomic impact....

Sponsor: Vincent Tay Khwee SoonEnrolling: 101 location
RECRUITINGNCT05929703

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

The goal of this clinical trial is to compare the Hospital Elder Life Program (HELP) with a family-augmented version of HELP (FAM-HELP), that includes family members and care...

Sponsor: University of MichiganEnrolling: 19007 locations
RECRUITINGNCT06801639

Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms

Participants will be asked to participate in this research study of a device that creates transcranial direct current stimulation (tDCS). The researchers hope to learn if 30...

Sponsor: The University of Texas Health Science Center at San AntonioEnrolling: 241 location
RECRUITINGNCT05592366

Dementia Care Partner Hospital Assessment Tool

The purpose of this study is to see whether an adapted questionnaire called the Care Partner Hospital Assessment Tool (CHAT) for care partners of hospitalized patients living with...

Sponsor: University of Wisconsin, MadisonEnrolling: 1281 location
RECRUITINGNCT06582199

Precision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort...

BioCogBankAD aims at building a prospective clinical practice cohort of 244 patients with biologically confirmed mild cognitive impairment due to Alzheimer's Disease (AD) or mild...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 2441 location
RECRUITINGPhase 1NCT06535308

BnH-015B Clinical Trial in Moderate Alzheimer's Disease

BnH-015B is a small molecule compound that targets the GluN2B binding site on NMDA receptors and positively modulates. BnH-015B has shown, through nonclinical trials, to improve...

Sponsor: BnH ResearchEnrolling: 921 location
RECRUITINGPhase 2NCT06014424

Cannabidiol Medication Intervention Trial

CALM-IT is a Randomized, double-blind, placebo-controlled cross-over clinical trial. Safety and efficacy of cannabidiol (CBD) capsules assessed for managing agitation in patients...

Sponsor: Sunnybrook Health Sciences CentreEnrolling: 405 locations
RECRUITINGNCT03671889

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with...

Sponsor: InSightecEnrolling: 5010 locations
RECRUITINGNCT05795634

Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease

The goal of this clinical trial is to learn about how genetics and the response to stress predicts cognitive decline in individuals with mild cognitive impairment. The main...

Sponsor: Johns Hopkins UniversityEnrolling: 2401 location
RECRUITINGPhase 2NCT07496918

Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)

Despite the huge healthcare and economic impact of AD, there is still no disease modifying therapeutics available. In fact, the available therapeutics show low efficacy at best in...

Sponsor: Massachusetts Institute of TechnologyEnrolling: 1501 location
RECRUITINGNCT03174938

The Swedish BioFINDER 2 Study

The Swedish BioFINDER 2 study is a new study that will launch in 2017 and extends the previous cohorts of BioFINDER 1 study (www.biofinder.se). BioFINDER 1 is used e.g. to...

Sponsor: Skane University HospitalEnrolling: 15052 locations
RECRUITINGNCT06631742

Exergaming Revolution in Dementia

This pilot randomized controlled trial evaluates the effect of a 12 weeks exergaming training in people with major neurocognitive disorders (MNCD) living in long-term care...

Sponsor: Eastern Switzerland University of Applied SciencesEnrolling: 481 location
RECRUITINGNCT07202494

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience...

The MESO7 study is a prospective observational research project designed to investigate the mechanisms of resilience and neurodegeneration in neurological diseases and healthy...

Sponsor: Assistance Publique Hopitaux De MarseilleEnrolling: 7001 location
RECRUITINGNCT05710549

Understanding Brain Mechanisms Involved in Autobiographical Memory

The overall objective of this project is to characterize the spatiotemporal dynamics of brain oscillations underpinning autobiographical memory (ABM) and the modulation of the...

Sponsor: Lucie BréchetEnrolling: 1201 location
RECRUITINGNCT06841848

Fundus Camera Module for Early Detection of Alzheimer's Disease

Alzheimer's Disease (AD) affects tens of millions of people just in Europe. It is typically detected in its late stage when irreversible damage has already occurred, and current...

Sponsor: I.R.C.C.S. Fondazione Santa LuciaEnrolling: 801 location
RECRUITINGPhase 3NCT07115238

Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD

The goal of this clinical trial is to evaluate the efficacy and safety of XTR006 injection PET visual reading in detecting brain neurofibrillary tangles (NFTs) in elderly subjects...

Sponsor: Sinotau Pharmaceutical GroupEnrolling: 3541 location
RECRUITINGNCT04844060

Cerebro Spinal Fluid Collection (CSF)

Cognitive neurodegenerative diseases are a major public health issue. At present, the diagnosis of certainty is still based on anatomopathological analyses. Even if the diagnostic...

Sponsor: University Hospital, Strasbourg, FranceEnrolling: 100001 location
RECRUITINGNCT07117162

Improving Access to Care for Veterans With Memory Loss

This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will...

Sponsor: VA Pittsburgh Healthcare SystemEnrolling: 301 location
RECRUITINGNCT05077579

Alzheimer"s Imaging Biomarkers in Obesity

High body fat at midlife, as evidenced by overweight or obese body mass index (BMI), is increasingly understood as a risk factor for Alzheimer's disease. However, the underlying...

Sponsor: Cyrus A RajiEnrolling: 2401 location
RECRUITINGPhase 2NCT06847321

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

This study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental decline in the last year and who have P. gingivalis...

Sponsor: Lighthouse Pharmaceuticals, Inc.Enrolling: 3001 location
RECRUITINGNCT06104852

Triage Survey for Neurology Research Eligibility

TRIAGE-Neuro is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored neurology clinical trials.

Sponsor: Adams ClinicalEnrolling: 6003 locations
RECRUITINGNCT06722352

Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)

The palliative care education in assisted living for dementia care providers (PCEAL-DCP) is a 4-week intervention (once a week for 1.5 hours, a total of 6 hours) for licensed...

Sponsor: University of South FloridaEnrolling: 7922 locations
RECRUITINGNCT06057909

A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease

The purpose of this research study is to investigate how the brain, memory, thinking, and motor behavior change both in individuals with movement and/or cognitive disorders, as...

Sponsor: Mayo ClinicEnrolling: 901 location
RECRUITINGNCT06529744

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and...

To develop a model to predict disease progression in a large cohort of patients across a variety of neurodegenerative diseases, including Mild Cognitive Impairment (MCI) and...

Sponsor: University Health Network, TorontoEnrolling: 5004 locations
RECRUITINGNCT07109999

Biomarker-based Alzheimer's Disease Cohort Study (BASIC)

This study adopts a prospective cohort design, constructing a single-center cohort by recruiting patients with Alzheimer's disease (AD) who are positive for AD biomarkers. First,...

Sponsor: Xuanwu Hospital, BeijingEnrolling: 28351 location
RECRUITINGNCT07021040

Olfactory Biopsies

This research study aims to investigate the function of the olfactory lining in the nasal cavity and its potential alterations in both healthy and diseased conditions. The...

Sponsor: Duke UniversityEnrolling: 1251 location
RECRUITINGPhase 1NCT06412185

Single Dose Escalation Study of CM383 in Healthy Volunteers

This study is a single center, randomized, double-blind, placebo-controlled Phase I clinical study in a single dose escalation to evaluate its safety, tolerability,...

Sponsor: Keymed Biosciences Co.LtdEnrolling: 561 location
RECRUITINGNCT06703541

ADRC Clinical Cohort (Alzheimer's Disease)

The purpose of the study is to establish a clinical cohort for the Duke/UNC Alzheimer's Disease Research Center (ADRC). The cohort will be composed of subjects ages 25 to 44 at...

Sponsor: Duke UniversityEnrolling: 5001 location
RECRUITINGNCT05596760

Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers

The goal of this clinical trial is to improve communication among clinicians, patients with memory problems, and their family members. We are testing a way to help clinicians have...

Sponsor: University of WashingtonEnrolling: 18003 locations
RECRUITINGNCT06669546

Effects of Real vs. Soundless Acoustic Stimulation During Deep Sleep on Brain Activity, Memory, and Blood Biomarkers in...

This study aims to explore a non-invasive way to improve memory and slow cognitive decline in older adults by enhancing sleep quality. Dementia, a leading cause of death...

Sponsor: University of BernEnrolling: 601 location

Showing 50 of 72 trials.Search all Alzheimer Disease trials